Tidal Royalty Corp. Adds Former NBA Player and Cannabis Entrepreneur Al Harrington to its Advisory Board

Cannabis Investing News

Tidal Royalty Corp. (CSE:RLTY.U) (“Tidal Royalty”), a leading provider of royalty financing to licensed U.S. cannabis operators, is pleased to announce that Al Harrington, former National Basketball Association (“NBA”) player and founder of The Harrington Group, has joined the company’s Advisory Board.

Tidal Royalty Corp. (CSE:RLTY.U) (“Tidal Royalty”), a leading provider of royalty financing to licensed U.S. cannabis operators, is pleased to announce that Al Harrington, former National Basketball Association (“NBA”) player and founder of The Harrington Group, has joined the company’s Advisory Board.

Mr. Harrington was a 1st round draft pick in 1998 and played 16 seasons in the NBA. Since his retirement from professional basketball, Mr. Harrington has become a prolific entrepreneur in the cannabis industry and an outspoken proponent of cannabis legalization. His name-sake company, The Harrington Group, is focused on promoting a healthier lifestyle and easing the suffering of its customers. The Harrington Group holds controlling interests in Viola Extracts (a top-selling national cannabis brand) and Harrington Wellness (a consumer health and wellness brand), and a non-controlling interest in Butter Baby (a leading producer of THC-infused butter).

Tidal Royalty’s CEO and Chairman, Paul Rosen, stated: “Mr. Harrington’s passion for this industry – borne out of his real-life experiences validating the therapeutic effects of cannabis – is truly unique and inspiring. With his success in building three noteworthy brands, and his previous career as an elite professional athlete, I am confident Mr. Harrington will contribute tremendously to the growth and success of Tidal Royalty”.

Mr. Harrington first became aware of the medicinal benefits of cannabis after suffering complications from knee surgery during his NBA career. He subsequently introduced his 80-year old grandmother to cannabis to help treat her pain caused by glaucoma and diabetes. Viola Extracts is named for her.

“Cannabis has had an incredibly positive impact on my health and that of those closest to me, which is why I chose to get involved in this industry. With The Harrington Group, I’m looking to develop reliable and safe products for both medical patients and casual enthusiasts,” stated Mr. Harrington. “I met the Tidal Royalty executive team one year ago, and I was impressed by their experience, ability to innovate, and dedication to helping develop the regulated cannabis industry in the U.S. We’ve since developed a strong relationship and I am truly excited about the synergies between The Harrington Group of companies and Tidal Royalty.”

Tidal Royalty will look to Mr. Harrington to provide strategic advice to management based on his experience as a cannabis industry leader and advocate. The parties are also exploring opportunities between Tidal Royalty and The Harrington Group of companies.

About Tidal Royalty

Tidal Royalty provides royalty financing to the U.S. regulated cannabis industry. Led by an executive team with extensive industry experience in Canada and the U.S., Tidal Royalty provides operators with the funding they need to grow their business. Operators benefit from non-dilutive capital and investors get top-line access to a diversified portfolio of companies that will form the future of this transformative industry.

For further information, please contact:

Tidal Royalty Corp.
Terry Taouss, President
Email: terry@tidalroyalty.com

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Readers are cautioned that forward-looking information contained in this new release is not based on historical facts but instead is based on reasonable assumptions and estimates of management. Forward-looking information contained in this news release includes, but is not limited to: the effectiveness of the company’s Advisory Board in providing strategic advice. In addition, this news release contains information and forward-looking statements attributed to third-party sources, the accuracy of which has not been independently verified by Tidal Royalty. Forward-looking information contained herein is based on the opinions and reasonable assumptions and estimates of management as at the date hereof, and is subject to a variety of known and unknown risks and uncertainties and other factors that could cause actual events or results of the company to differ materially from those expressed or implied in the forward-looking information. Such factors include: U.S. regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change, risks relating to anti-money laundering laws and regulation, other governmental and environmental regulation, public opinion and perception of the cannabis industry, risks related to the enforceability of contracts, the requirement by the company to obtain additional financing, the limited operating history of the company, timeliness of government approvals for granting of permits and licences needed by any future investee companies, including licences to cultivate cannabis, the actual operating and financial performance of any future investee company may differ materially from that anticipated by the company, competition and other risks affecting the company in particular and the U.S. cannabis industry generally and the risk factors effecting the company disclosed in the listing statement of the company available at www.sedar.com. Because of such risks, uncertainties and other factors, investors should not place undue reliance on the forward-looking information contained herein. The company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. The foregoing statements expressly qualify the forward-looking information contained herein. This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Source: www.newsfilecorp.com

The Conversation (0)
×